Neurogait Overview
Neurogait is developing AI based clinical screening for curable dementia, Parkinson's and other neurodegenerative Disease. It has conducted a successful clinical trial in Sheba Medical center and is an innovative Partner of Sheba ARC Innovation arm. It is currently pursuing clinical pilots in the EU and is in the process of applying for an MDR CE as a type 2a Medical device.
Cumulative Funding Raised Over Time ($)
Latest News
Growth-Positive
Neurogait: Creating an AI-based ecosystem for neurological disease
The article discusses four companies: Neurogait, Albert Health, Bold Health, and DocHQ. Neurogait, led by CEO Eyal Fruchtman, is developing an AI-based ecosystem for neurological diseases. Albert Health, led by CEO Serdar, is a voice-based health assistant that helps people manage their chronic diseases. Bold Health, co-founded by Elena Mustatea, is a digital health company that provides holistic gut care. DocHQ, founded by Madhur Srivastava, is an employee benefits provider that uses technology to enhance employee wellbeing at work and home. All four companies are leveraging AI and other technologies to improve healthcare and patient outcomes.
CustomersPartnersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.neurogait.com/ |
Locations
Ranana, Israel
Photos & Videos
No files yet
